Arialief Criticism Reviewed: The Tainted Neuropathy Relief Controversy Published

Arialief Criticism Reviewed: The Tainted Neuropathy Relief Controversy Published Unmasking the Truth About Arialief: Honest Reviews, Ingredient Warnings, and the Real Reasons Behind User Complaints GlobeNewswire May 15, 2025 In This Arialief Review, You'll Discover: What Arialief is and how Arialief is marketed as a top neuropathy support supplement The real root causes behind neuropathic […]

RapDev Recognized on Boston Business Journal’s 2025 Fast 50 List for Third Consecutive Year

RapDev has once again been recognized as one of Massachusetts' fastest-growing private companies, earning the 9th spot on the Boston Business Journal's 2025 Fast 50 list. This marks the third consecutive year RapDev has made the prestigious ranking, highlighting its sustained growth and leadership in DevOps, IT automation, and AI-driven service operations. https://mma.prnewswire.com/media/2688567/RapDev_Social_Posts_Week_19_02.jpg “We are

Aleran Software’s Digital Commerce Platform Is Certified by SAP as Built with SAP Business Technology Platform

MINNEAPOLIS, May 15, 2025 (GLOBE NEWSWIRE) — Aleran Software announced today that its digital commerce platform is now certified by SAP(R) as built with SAP Business Technology Platform (SAP BTP), SAP's platform for the Intelligent Enterprise. Aleran helps mid-market B2B manufacturers, wholesalers and distributors quickly and easily orchestrate omni-channel B2B sales and commerce. It does

Aleran Software’s Digital Commerce Platform Is Certified by SAP as Built with SAP Business Technology Platform

Aleran Software's Digital Commerce Platform Is Certified by SAP as Built with SAP Business Technology Platform Aleran's connected commerce platform helps manufacturers, wholesalers, and distributors accelerate sales and grow revenue by simplifying and orchestrating complex B2B sales GlobeNewswire May 15, 2025 MINNEAPOLIS, May 15, 2025 (GLOBE NEWSWIRE) — Aleran Software announced today that its digital

RECORDATI: TO BE HIGHLIGHTED AT AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY (AACE) ANNUAL MEETING–THE EXPANDED INDICATION FOR ISTURISA® (OSILODROSTAT) FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN ADULT PATIENTS WITH CUSHING’S SYNDROME FOR WHOM SURGERY IS NOT AN OPTION OR HAS NOT BEEN CURATIVE

— ISTURISA® (osilodrostat) is a cortisol synthesis inhibitor that blocks the enzyme 11beta-hydroxylase to help normalize hypercortisolemia in Cushing's syndrome, a rare endocrine condition that can have significant impact on patients and their families — The expanded indication is supported by an extensive clinical development program Today,Recordati RareDiseasesInc.announced that further insights into ISTURISA®as well as

CASAMIGOS TEQUILA INTRODUCES “ANYTHING GOES WITH MY CASAMIGOS”

A NEW GLOBAL CAMPAIGN FOR THIS AWARD-WINNING TEQUILA Casamigos Tequila announced today the launch of its global creative campaign, “Anything Goes with My Casamigos.” Bright, bold, and fun, the campaign, developed in partnership with creative agency Accomplice and director Alex Prager, celebrates unexpected connection and friendship, highlighting the ease and approachability of the brand's award-winning

Avantax Acquires Assets of WealthCare Financial with Approximately $180 Million in Assets Under Administration

Tax and financial planning firm deepens partnership with Avantax to help ensure a consistent experience for clients and positive futures for employees Avantax® Inc. (Avantax), a unique community within Cetera and a leader in tax-focused financial planning and wealth management, has acquired the assets of WealthCare Financial Group LLC, an Indianapolis-based tax and financial planning

Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments

(NASDAQ:REGN), Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent(R) (alirocumab) from competing in the market Jury awarded Regeneron $135.6 million dollars of compensatory damages and $271.2 million dollars in punitive damages TARRYTOWN, N.Y., May 15, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ:

Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments

Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments GlobeNewswire May 15, 2025 Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent(R) (alirocumab) from competing in the market Jury awarded Regeneron $135.6 million dollars of compensatory

Digimarc Corporation Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights – DMRC

(NASDAQ:DMRC), NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Digimarc Corporation (NASDAQ: DMRC). Shareholders who purchased shares of DMRC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

Scroll to Top